InvestorsHub Logo
Followers 177
Posts 11263
Boards Moderated 0
Alias Born 04/04/2011

Re: None

Tuesday, 02/04/2014 5:36:47 PM

Tuesday, February 04, 2014 5:36:47 PM

Post# of 27076
Some NRTI DD for new investors:

I am going back and posting the highlights from my previous post to give you a good glimpse into this company and why it has so much going for it. I will post the most recent first followed by the next most recent post. Please feel free to ask any questions on this board. I also speak with the CEO regularly and I announce my phone calls prior to us speaking, so folks here can submit their questions to me to get answered by the CEO when we talk. The ceo is also open to talking to any investor when he has the time, so also feel free to call him yourself too. Also check out the ibox/intro page for additional info. I will be updating it with these newest developments when I get a chance. Cheers!

Current NRTI product lines: SURGEX, MARTHA STEWART ESSENTIALS SUPPLEMENTS FOR WOMEN, BIKINI READY, & SLIM TRIM.

1/2 page Surgex ad that ran in the USA Today Superbowl Edition:


Jan 21st Post:

Just the FACTS please!

#1 I can guarantee you without a shadow of a doubt, that the company is not selling any shares, nor have they for a very long time. I don't understand why these statements keep coming out. The company would be required to do a filing immediately if they were selling shares and I would entertain anyone to call the company and ask the CEO, Mr. James straight out if they sold any shares.

#2 4th qtr earnings are not going show what some expect. It will not show the $3 mil they received from The NJ tax program, that is to be received this month, which will show up in their 2014 1st qtr earnings report that will come out in May of this year.

Also, Mr. James previously announced that they would not be able to recognize the large 3rd qtr shipments of MSE to Walgreens until the 1st qtr of 2014. Thus those who will base their selling decisions upon this showing up in their 4th qtr earnings can already do so, because it won't be in there. In fact to be clear, the 4th qtr is the slowest time for sales of these type of products that the company sells. That too was previously disclosed by the CEO and posted here.

#3 The 1st qtr is typically the largest qtr for sales on the products that the company sells.

#4 The company just recently announced the expansion of two of their product lines, Surgex and Bikini Ready.

#5 The company just finished up at a recent trade show that produced some great opportunities for expanded distribution for all the product lines by the company. This will be in addition to the recent announcements of expanding distribution into HyVee and Cardinal Health.

#6 The company just recently hired a world class IR Firm, RLM Finsbury, who wrote up the most recent PR for the company. This firm just came aboard and it would be unreasonable to expect immediate impact on the share price, but it should pay off for the company and its investors in the coming months.

#7 AND THE MOST IMPORTANT OF ALL! It would be very safe to assume that NRTI's 1st qtr earnings will be the biggest in the company's history and be well above any and all previous quarters by the company. Here's why:

* The company will be reporting the $3 million they received from the state of NJ Tax program.

* The company will recognize the huge 3rd qtr shipments of MSE to Walgreens in the 3rd qtr of last year. We already know that this amount that they had to defer was around $1.4 million in sales. I am not sure if much of that will be recognizable in the company's 4th qtr earnings, per Mr. James.

* The company will be reporting sales from their peak time of the year for all their products with the addition of their newly expanded product line up for Surgex and Bikini Ready that was introduced at the beginning of the quarter.

* Any additional distribution during this 1st qtr that is recognizable will be in addition to what can currently calculate.


I am just trying to ensure that everyone has the right facts and expectations as we head into this new year. I am not trying to cloud the issue with any possible projections, as that is not well received by everyone, so I am just stating the facts as we know them. However, when considering the facts, it is without a doubt, safe to easily assume that the 1st qtr earnings report will be the largest and most impactful for the company since it's existence. That is just using plain common sense based on the facts to date.

It would seem to be rather prudent as not to expect too much from this upcoming 4th qtr report, since it is typically the slowest qtr for their product sales and that the company won't be able to recognize the bulk of their sales from their initial shipments to Walgreens from the 3rd qtr, nor the $3 million from their Tax program. That will be recognized in their 1st qtr earnings.

Looking at NRTI's chart it seems we are at or very near a confirmed bottom with little room for the share price to sink much lower, but one can't ever completely rule out the improbable when dealing with OTC stocks.

As for me, I will continue to add from time to time on any dips below 9 cents. I think the company is progressing very well and eventually the stock price will respond accordingly. In the end we all know it will come down to product sales, which is what Mr. James has stated all along. The company continues to explore all possibilities to increase sales that is cost effective. I think in the longer term their new IR Firm will play a big role to increase investor awareness that will increase the liquidity in the stock.

I think we we all were a little dismayed about the stock current stock price, as is Mr. James, but he is taking the necessary steps to help improve that this year. It is clear that this investment will require more patience for those who can tolerate to do so. For those who don't, they will continue to look for an exit when the opportunity arises. This is what we are seeing currently. Every time the stock price moves up a little, we see new sellers enter the picture. This is what is happening, along with our continued big seller from the company's past that has been ever present for so long. The day MAXM disappears is the day this stock will truly move to new heights.

Everyone has their own investing rules and we shouldn't be upset that they sold and moved on. I think it is imperative to stay tuned to the real facts and block out the useless noise from those who are not in tune to the reported facts. JMHO



Jan 16th post:

News: Inergetics Congratulates Surgex' Sports Nutrition Spokesperson Keenan Allen of the San Diego Chargers on being Named NFL Offensive Rookie of the Year

January 16
9:13 2014
by Geeks News Desk

Inergetics Congratulates Surgex' Sports Nutrition Spokesperson Keenan Allen of the San Diego Chargers on being Named NFL Offensive Rookie of the Year

NEWARK, N.J., Jan. 16, 2014 /PRNewswire/ Inergetics, Inc. (NRTI), a leading developer of nutritional supplements, today offered its congratulations to Keenan Allen of the San Diego Chargers on being named the NFL Offensive Rookie of the Year by the Professional Football Writers of America.

Selected with the 76 th overall pick by the Chargers in April's 2013 NFL draft, Allen is a spokesperson for Inergetics' Surgex Sports Nutrition line of nutritional supplement products.

"We're very proud to have Keenan as a member of the team here at Inergetics," said Jim Kras, Chief Marketing Officer. "As a spokesperson for Surgex Sports Nutrition, Keenan exemplifies everything our growing line of Surgex products delivers to athletes consistent performance and a commitment to excellence."

Utilizing a variety of Surgex Sports Nutrition products to help with his daily training regimen, Allen led all rookies during the 2013 regular season with 71 catches, 1,046 yards receiving and eight touchdown receptions and was ultimately named the NFL Offensive Rookie of the Year. Allen capped off his rookie season with an outstanding performance in the NFL Divisional Playoff Round against the Denver Broncos last Sunday contributing with 6 receptions for 142 yards and two touchdowns.

Surgex Sports Nutrition, the preferred nutritional supplement of Army Sports, recently unveiled a new line of products, Surgex Warrior, to provide warriors like Keenan with specialized pre, during and post workout performance formulas designed to assist in training.

Surgex is a clinically studied performance enhancing formula designed to build lean muscle and increase energy to obtain peak levels of power and stamina.



Jan 14th post:

Confirmed! NRTI has hired RLM Finsbury as their new IR Firm!

Mr. James did confirm that they have in fact hired the world renowned, high caliber, RLM Finsbury as their new IR Firm. I think this speaks volumes as to the caliber of this company and where they are headed. They are associating themselves with a high quality, well respected outside firm to represent them in this capacity. I think in due time this will all equate into a higher share price that better reflects the company's value. None of us, including Mr. James isn't happy where the share price is currently and eventually this will correct itself.

I for one am really taken back by them hiring such a quality international firm to represent them and attract new investors to this stock. I will be calling Paul Cafiero, from RLM Finsbury in the near future to get his take on the company and post what he has to share. In closing, I can only say that I am glad I chosen to invest as much as I have here for the long term, as I can easily envision the company's long term success much better now.

RLM Finsbury is a global leader in strategic communications and a trusted adviser to many of the world's most successful companies, institutions and organizations.

With offices in the U.S., Europe, the Middle East and Asia, RLM Finsbury provides expert counsel and support to clients around the world on interactions with the media, financial markets, employees, customers, governments and regulators, and other vital stakeholders.

The firm has managed some of the most complex communications challenges, financial issues, reputational matters and other corporate crises of the last three decades. These include high-profile litigation, mergers and acquisitions, executive changes, restructurings and proxy fights, as well as brand positioning campaigns, product launches, advocacy campaigns, congressional investigations, legislative initiatives, labor matters, regulatory reviews and long-term reputation and employee engagement efforts.

We work extensively with corporations in the Fortune 500, FTSE 100 and Eurofirst 300, as well as other public and private companies, academic institutions, associations, major nonprofits and NGOs around the world.

RLM Finsbury designs and implements communications programs that help: support clients' goals and missions; protect and advance reputations; build and strengthen brands; expand market opportunities; and enhance bottom-line success.

Our more than 200 communications professionals bring a wealth of experience in finance, law, public policy and journalism, as well as the global expertise, insight and judgment to help clients make the greatest impact in their interactions with the media, financial markets, employees, customers, policymakers, regulators, and other vital stakeholders.

The firm's work is defined by a tireless commitment to its clients, intellectual rigor, meticulous attention to detail, strict confidentiality and a relentless focus on execution and results.

RLM Finsbury was created from the merger of Robinson Lerer & Montgomery (RLM) , founded in 1986 in New York City, and Finsbury, founded in 1994 in London, and is part of WPP, the world’s largest communications services network. The firm has offices in Europe (London and Brussels), the United States (New York, Washington, D.C., and Los Angeles), Asia (Greater China and Singapore), and the Middle East (Abu Dhabi and Dubai).



Dec 23rd post:

Inergetics Awarded $3.3 Million from New Jersey Technology Business Tax Certificate Transfer Program

NJ Economic Development Authority Grant Will be Reinvested in the Business to Enhance Product Development and Distribution Initiatives
PR Newswire Inergetics, Inc.


NEWARK, N.J., Dec. 23, 2013 /PRNewswire/ -- Inergetics, Inc. (NRTI), a leading developer of nutritional supplements based in Newark, NJ, announced today that its application for the New Jersey Technology Business Tax Certificate Transfer Program has been approved for $3.357 million.

Inergetics, which employs twelve full time employees of which eleven are located in New Jersey, relocated to the Innovation Zone of Newark, NJ in 2013 and expects to receive cash after fees of $3.055 million in January of 2014. The state funding is non-dilutive and does not add shares or debt to the capital structure of the company.

"We are very pleased to have been selected for the New Jersey Economic Development Authority's program for the second year running. This funding will be reinvested into the business to help us expand the company within the great state of New Jersey," said Mike James, CEO. "We chose to locate our company in the Newark Innovation Zone and are thrilled to be a part of the state's growing health and science sector."

Inergetics will utilize these working capital funds to expand its product offerings and achieve greater distribution of its existing product lines, including Martha Stewart Essentials, Bikini Ready, SlimTrim and Surgex Sports Nutrition.



Dec 13th Post:

Checkout Martha's Blog today! Mr. James just alerted me and sent me the link to it. Make sure you read the great comments she is receiving in response to her "Martha Stewart Essentials". Looks as Martha is starting to take a more active role in promoting her supplements. Cheers!

www.themarthablog.com/2013/12/our-line-of-martha-stewart-essentials.html/comment-page-1#comment-155139



DECEMBER 13, 2013
Our Line of Martha Stewart Essentials

Recently, The New York Times ran a fascinating article about the importance of vitamins to the human body. Click here to read the article. I have always been a firm proponent of taking vitamin supplements and I really understand their benefits. I have to confess, however, that I was never quite satisfied with what was available commercially and felt it was time to help create something that could become an affordable part of women's everyday health routine. We partnered with the wonderful company Inergetics, a leading developer of nutritional supplements. Working closely with their science experts, we developed six formulas guided by science and holistic medicine, using natural, whole-food ingredients such as fruits, vegetables, and herbs. The formulas focus on specific needs (Graceful Aging, Digestive Health, Bone Support, Menopause Support, and Hair, Skin & Nails) as well as supporting overall health and wellness (Women's Multivitamin). I hope you'll try these supplements and please let me know what you think. They're available at Walgreens.



Dec 11th Post:

I spoke w/Mr. James this afternoon as he took time out of his very busy schedule to call me.

IR Firm:
He stated that he has met with a potential IR firm and discussed what NRTI was all about and the products that they carried. I tried to get an idea of when we could expect something and he said straight out that he can't discuss the issue beyond that he met with a firm, as it would be a violation to do so and I understood completely. Just know that he continues to pursue the issue and will have an announcement when something is concrete.

Tax Credits:
As for the issue on the tax credit notification, he stated that he expects it any day, but can't be assured of when it will happen exactly, as it is in the hands of the state as to when they will notify him. However, he stated that we can rest assured that we will hear something as soon as he is notified. Last year it was at this time that they were notified and though he expects the same this year, there is no real guarantee as to when it will actually happen this year.

Intrinsix - Podiatree Deal:
In regards to the Intrinsix deal with Podiatree, this is how it is setup. Podiatree has contracted with an outside source to go out and sell this to the podiatry offices during their sales calls to the various podiatry offices. Mr. James is waiting to hear back if they are allowed to tell him who the outside agency is, but said it would be similar to what you see with Cardinal Health, and for that matter we don't know for sure if it isn't Cardinal Health at this time.

As I previously thought and expressed here, it was an easy low cost type of deal that could bring in sustainable profits for the company down the road. He said it could in time provide a very nice recurring revenue for the company and could end up growing into something much bigger in the longer term, making it an easy deal to accept for the company. The upfront cost of producing the product is their upfront cost and given that they don't need to provide anything beyond producing it to make a decent margin, and that it was great supplement that fit well into their portfolio of products, it was an easy decision for the company.

Press Releases:
Mr. James said that investors need to know that while the time in between meaningful PR's may be longer than they wish sometimes, rest assured the company is busy and hard at work following through on all that needs to happen to sustain and grow the company. He will not put out a PR just for the sake of having a PR every 2 to 4 weeks, he will only put out a PR when there is something noteworthy to report about the company. In other words, don't expect any fluff PR's, which is what most of us investors agree with!

Share Price:
He said though he too wished the share price was higher than we are currently seeing, he is working hard to ensure the company's long term success and providing as much exposure as possible for the company and its investors through the RIGHT sources by utilizing the best methods to accomplish the task.

Future Outlook for the brands:
He remains very positive on the company's outlook for the upcoming year and said that the big sales growth will come through their continued distribution opportunities in 2014 for all the brands. This continued expansion with continued exposure for the brands via FSI's, coupons, radio, magazines, etc will drive the necessary sales to keep the company moving in the right direction and sustain its operational & promotional cost.

In Closing:
He and his management team have been very busy lately traveling around the country to keep everything progressing. He took the time out of his busy schedule to call me this afternoon, even though his flight did not get in until 2:30 this morning. I was extremely grateful for his call and what he was able to share with me. I remain very optimistic about the future for NRTI and its long term success with the all NEW management here.



Dec 9th Post:

Inergetics' Carl Germano to be Featured on "Martha Live" on Tuesday, December 10th
Date : 12/09/2013 @ 9:00AM
Source : PR Newswire (US)
Stock : Inergetics, Inc. (QB) (NRTI)

Inergetics' Carl Germano to be Featured on "Martha Live" on Tuesday, December 10th
Today : Monday 9 December 2013

NEWARK, N.J., Dec. 9, 2013 /PRNewswire/-- Inergetics, Inc. (OTC-QB: NRTI), a leading developer of nutritional supplements, announced today that its Chief Science Officer, Carl Germano RD, CNS, CDN, will be joining Martha Stewart for her daily radio show "Martha Live" on SiriusXM Radio on Tuesday, December 10th. Martha and Carl will be discussing general health and nutrition topics, as well as Martha Stewart Essentials, a complete line of whole-food-based supplements specially created for women by Inergetics.

Carl is a NY Board Certified Clinical Nutritionist who holds a master's degree in clinical nutrition from NYU and has over 30 years' experience using innovative, complementary nutritional therapies in private practice and in product development. For the past three decades he has been instrumental in bringing cutting-edge nutritional formulations to market and served as VP of Product Development with companies such as Solgar, Country Life, Nutratech and others. Carl has also published eight books – his most recent being "The Misled Athlete: Effective Nutritional & Training Strategies Without the Need for Steroids, Stimulants and Banned Substances."

Martha Stewart Essentials is available nationally in chain drug stores. More information may be found at www.marthastewartessentials.com/. Schedule and other information about "Martha Live" is available at http://www.siriusxm.com/marthastewart.



Dec 3rd Post:

New PR out about a new product launch!

Inergetics Announces Launch of Intrinsix, a Pharmacist-Formulated Supplement to Support Healthy Nerve Function and Foot Health
Date : 12/03/2013 @ 9:00AM
Source : PR Newswire (US)
Stock : Inergetics, Inc. (QB) (NRTI)

Inergetics Announces Launch of Intrinsix, a Pharmacist-Formulated Supplement to Support Healthy Nerve Function and Foot Health

NEWARK, N.J., Dec. 3, 2013 /PRNewswire/ -- Inergetics, Inc. (NRTI), a leading developer of nutritional supplements, and The Podiatree Company, a leader in podiatry pharmaceuticals, today launched Intrinsix — the only podiatry-exclusive nerve health support supplement enriched with calcium and vitamin D.

Developed alongside pharmacist, Robert Graci, R.Ph., Inergetics has created a unique formula to support healthy nerve function and specifically help diabetic patients who experience nerve-related symptoms in their extremities, which include tingling, pain, burning, and loss of sensation.

"With approximately 15,000 podiatrists practicing in the U.S., we are taking a direct sales approach to help them support the ever-increasing proportion of the population suffering with diabetes," said Inergetics CEO Mike James. "Intrinsix is a great addition to the Inergetics family and we look forward to continuing our work with The Podiatree Company to advance foot care for the benefit of patients."

"As a company dedicated to the podiatry specialty market, we take pride in being able to provide our physician partners with unique and efficacious specialty products to meet their patients' needs," added Robert Graci, R.Ph.

Intrinsix contains a unique pharmacist-formulated blend of alpha lipoic acid, benfotiamine, calcium, and vitamins B6, B12 and D. The formula is safe for patients with strict dietary restrictions, including vegetarians and those with sugar-free, sodium-free and starch-free diets.

Intrinsix has been distributed for sale to local podiatrists across the U.S. and will be available immediately to their patients.



Nov 27th Post:

2014 will be an exciting year for NRTI

The facts clearly point to NRTI recording an extraordinary 1st quarter that will be off the charts! It will include the huge 3rd qtr 2013 sales in addition to the big sales during their peak season that can be recorded in the 1st quarter, but also the huge tax credits that will be added to their bottom line. Though I realize this will not come out until mid May of next year, it will set the tone of where the company is headed in 2014. This will give the new IR firm plenty to talk about well ahead of their 1st qtr filing in May of next year.

Until then we will have these newsworthy events:

Tax Credit Announcement - 2nd week of December 2013 (They applied for the remaining balance of $3.2 million - Last year they received $2.2 million)

New distribution deals - ongoing

Promotional activity for all the brands - ongoing (Jan - March is historically the peak qtr for all their brands).

4th qtr earnings - Mid Feb 2104 (Oct - Dec is historically the slowest qtr for their brands).

1st qtr earnings - Mid May 2014.


Mr. James also stated he will consider doing a conference call or a letter to the shareholders to keep them abreast of the company's progress.

What you won't see is fluff PR's or any paid stock promotions. They have no need to artificially pump up the share price with these type of activities, since they are not looking to sell shares and dilute shareholders to raise money. This will come in the form of revenue from increased sales and the tax credits they will receive. The only dilution that will be noticed is from the restructured debt where they have an agreement to pay dividends and interest. It is management's objective to work on eliminating the debt and having holders of notes to start converting their shares when the share price starts getting above $.30. Thus it is in the company's interest to have their share price fairly valued in the market and to increase shareholder value.

The new management has a plan and are actively working the plan to meet all their objectives. Thus far they have proven that they are up to the task, as seen by their huge accomplishments in their very 1st year. It is with this that I trust the company is doing what is right to turn the company around and increase shareholder value for the long term. The addition of the new IR firm will be a huge step in creating investor awareness and bring back the much needed liquidity for their stock.

I look forward to a very prosperous 2014 and beyond and I am pleased to be in at the ground level as the new management turns this into a viable income producing company for the future with great brands and proper promotional activity for continued sales growth.



Nov 26th Post:

Why is NRTI a great investment? What can we expect for the rest of 2013 and all of 2014?

NRTI is focused on increasing the distribution throughout 2014 to get fully saturated in the market before investing into the high cost TV commercials. They will be focusing all their marketing efforts into a more direct approach for their current customers and new distribution. By a direct approach, I mean in the way of FSI's w/couponing to target populations, along with various digital media to spit out an instant coupon while the customer is in the process of shopping the department. We are in a all new age of digital advertising and social media advertising to reach the right customer in a much more effective way. Hard for me to comment much on this, since this is the new age of advertising that I was not a part of.

Given the advertising expertise on their board, I have to assume they know what they are doing. I do know the CEO, Mr. James, mentioned that they used well researched data in deciding the best approach for this category. From what I understood, they would be utilizing this strategy until they have achieved optimal distribution in the US market. It makes sense when you really think about it, as they can grow sales more at this stage by continuing to increase new distribution and getting the product on more retail shelves and accessible to more customers than spending a ton of money on advertising at this early stage. The FSI's w/coupons are proving to be a successful approach at this stage and that will now be further supplemented by digital advertising and in-store promotions w/displays.

To be honest I think we are seeing a more lengthy soft roll out than what we first expected. I believe the slower roll out pace was due primarily as to when many of these retail chains were open to taking on new products. I think we will see a constant addition of more and more chains throughout the first half of 2014, which is 6 months longer than previously thought.

Though it was somewhat of an initial letdown, from a business standpoint it was just the way it is structured and they had no choice but to work within the parameters of the retail system for securing new distribution on their timing, which has caused a delay in getting the MSE line into the distribution channels they targeted. This category is not the easiest to gain new distribution, due to all the products that are competing for the shelf space. They are currently very focused on securing additional distribution and are working very hard to ensure they are included in all the new distribution plans for each retail chain they have targeted, when the opportunity is available to add new products to their plan-o-grams.

In essence, 2014 will be an important transitional period for the company, as they concentrate on expanding all their product lines at the retail level through the targeted retail chains. This expansion will be the key driver for increasing sales quarter over quarter and get them to a cash flow positive state next year. Promotional support will be specifically tailored for each retail chain to promote trial and pull through. To date this expansion into the retail chains has proven to be a key driver in successfully growing ALL the brands. This is expected to continue throughout 2014 and beyond, with the majority coming in the first half of 2014. This growing retail distribution will ensure the company with continued large revenue growth for each and every quarter ongoing that will greatly outpace previous years sales.

It is the new management's goal to make NRTI into a viable growing business that will provide sustained revenue to support the company's operational cost and get them to a cash flow positive state as soon as possible. Plus the company has additional funds coming in the form of a huge tax credit they will receive very shortly and announced the 2nd week of December. Last year they received $2.2 million from the $5.4 million available, and this year they have submitted for the remaining balance of $3.2 million, which they are well positioned to receive. These tax credits are converted into cash by selling them to larger corporations who need the tax advantage. These funds then go straight to NRTI's bottom line and used to support their ongoing operational and promotional cost, without the need to turn to dilution to support these cost during this important transitional period of turning this company completely around.

The turn around in this company is directly attributed to the new CEO and his new management team that came in a year ago and made huge changes to quickly increase sales with new brands. One of which they created themselves was the Martha Stewart Essentials whole food supplements for women that was branded through the use of Martha Stewart via a royalty agreement. This has already contributed to a huge influx of $1.4 million in initial sales to fill the Walgreen retail chain of over 8,000 stores. Though this led to a 17,000% increase in sales in this 3rd qtr vs prev yr 3rd qtr, it could not be accounted for in the 3rd qtr due to the terms of the sales and proper accounting principals. Thus these sales will be recordable during the 1st qtr of 2014. This however does not take away from they accomplished so quickly to get this initial distribution. They went on to add the HyVee chain and Cardinal Health recently, with more coming soon. We now await to see how the initial product launch is selling at the retail level, which should be available next qtr.

We also saw some great increases in the 3rd qtr on their newly revamped Surgex product line, and the two newly acquired brands from earlier this year, Bikini Ready and Slim Trim. Given how the 4th qtr is historically a slow month for all these types of products, due to consumers setting aside their health & fitness goals for the holidays. Thus sales will most likely see a slight decrease this qtr. However, the 1st qtr is historically the best time for these type of products as consumers concentrate on getting healthy after the holidays and make their new years resolutions to get fit.

This all adds up to an unbelievable 1st qtr! Whereas, NRTI will now account for the 17,000% increase in sales they did in the 3rd qtr, realizing the huge increase in sales from their other brands during the best qtr of the year, and let's not forget about the huge tax credits they will be realizing in the 1st qtr. This 1st qtr will then be a qtr of unimaginable huge gains that will definitely go down as the biggest qtr for the company for a very long time. This will be an absolutely great way to start their big transitional year to get to a cash flow positive state! This will cause the street to take big notice of what new management has done to truly turn this company around.

As you can see there is much to look forward to this year with NRTI, making it a great time to add this company to your 2014 portfolio, while the share price is at a ground floor level. Meanwhile, we will see upcoming announcements in regards to the tax credits the 2nd week of December, that is HUGE, a new addition of an Investors Relations company the CEO has been working on, and not to forget, the additional distribution deals that will be forthcoming and ongoing.

There is not a better time to take advantage of this special ground level opportunity into a company trading at such a discount price. Remember, though NRTI is listed on the OTC market, it in no way operates like what you expect in the OTC market. The CEO operates this company like what you see on the bigger exchanges. Whereas, he says the share price will be determined by the sales and revenue performance and not by paid promotions and fluff PR's designed to artificially push the share price up. Thus he will not ever participate in such activities here, nor rely on dilution to sustain the company, but rather revenue created by increasing sales. He is in search of a reputable IR firm with a great track record that is used by the bigger companies and not any of these penny stock promoters we are used to seeing in the OTC markets.

Making NRTI a great long term stock for all of 2014 and beyond. A stock that could hand early investors as much as 1,000% gains as they become cash flow positive with increasing sales and revenue each and every qtr! Do your DD to see for yourself what new management has accomplished already and where they are headed in 2014 and beyond.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.